Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Jyotsana, N; Sharma, A; Chaturvedi, A; Scherr, M; Kuchenbauer, F; Sajti, L; Barchanski, A; Lindner, R; Noyan, F; Sühs, K-W; Grote-Koska, D; Brand, K; Vornlocher, H-P; Stanulla, M; Bornhauser, B; Bourquin, J-P; Eder, M; Thol, F; Ganser, A; Humphries, R K; Ramsay, E; Cullis, P; Heuser, M (2018). RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo. Leukemia, 32(1):224-226.

Dafflon, C; Craig, V J; Méreau, H; Gräsel, J; Schacher Engstler, B; Hoffman, G; Nigsch, F; Gaulis, S; Barys, L; Ito, M; Aguadé-Gorgorió, J; Bornhauser, B; Bourquin, J-P; Proske, A; Stork-Fux, C; Murakami, M; Sellers, W R; Hofmann, F; Schwaller, J; Tiedt, R (2017). Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia. Leukemia, 31(6):1269-1277.

Bourquin, J P; Bornhauser, B (2010). Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age? Expert Review of Hematology, 3(4):369-372.

Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010). Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115(5):1006-1017.

This list was generated on Wed Sep 18 01:04:21 2019 CEST.